The primary endpoint was the presence of increased RCG, defined as, the presence of solids, thick liquids, or more than 1.5 mL/kg of clear liquids on gastric ultrasonography. Among the 124 subjects (median age, 56 years, 60% female), the prevalence of increased RGC was 56% (35 of 62) in subjects with GLP-1 RA use compared with 19% (12 of 62) in subjects not taking a GLP-1 RA drug
Patients who havent succeeded with behavioral approaches alone
This episode is a call to action for patients and providers alike to rethink what subclinical really means, and to prioritize outcomes over outdated lab thresholds
All client results Before/after photos numbers timelines reviews Other Retatrutide dosages Buy Retatrutide 40 mg in Ukraine Buy Retatrutide 40 mg (ALLUVI) next-generation triple GLP-1/GIP/glucagon agonist from DOZA
But so have the forces pushing patients toward compounding in the first place: brand drugs priced out of reach, limited insurance coverage, and middlemen who distort access
These are not cosmetic products
